Analysis Of Income And Expense [Abstract]

Xbrane Biopharma - Filing #702449

Concept 2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Analysis of income and expense [abstract]
Material income and expense [abstract]
Research and development expense
160 619 SEK
197 284 SEK
Finance income (cost)
2 643 SEK
690,000 SEK
Miscellaneous other operating expense
4 126 SEK
11 203 SEK
Comprehensive income, continuing and discontinued operations [abstract]
Comprehensive income
1 220 SEK
187 156 SEK
188 376 SEK
226 026 SEK
228 800 SEK
2 774 SEK
Comprehensive income attributable to owners of parent, continuing and discontinued operations [abstract]
Comprehensive income, attributable to owners of parent
187 156 SEK
228 800 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.